Activated T-cells are a crucial part of the body’s adaptive immune system, specifically designed to identify and eliminate abnormal or infected cells. When a T-cell recognizes a cancer cell through its T-cell receptor (TCR), it binds to antigens displayed on the cancer cell’s surface via major histocompatibility complex (MHC) molecules. This recognition triggers the T-cell to release cytotoxic molecules such as perforin and granzymes. Perforin forms pores in the cancer cell membrane, allowing gr